Carbinoxamine Maleate
- Strength
- 6 mg/1
- Form
- Tablet
- Class
- Histamine-1 Receptor Antagonist
TRIPOINT THERAPEUTICS, LLC
Not stocked by us — reference only
Listed by Genus Lifesciences Inc.
| Dosage form | Tablet |
|---|---|
| Route | Oral |
| Drug class | Histamine-1 Receptor Antagonist |
| Approval route | ANDA — approved generic |
| NDC code | 64950-211 |
| FDA application | ANDA040442 |
| RxNorm concept | 1010696 |
| Package sizes listed | 1 |
| Marketed since | August 2023 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
TRIPOINT THERAPEUTICS, LLC
Not stocked by us — reference only
Biocomp Pharma, Inc.
Not stocked by us — reference only
Leading Pharma, LLC
Not stocked by us — reference only
Genus Lifesciences Inc.
Not stocked by us — reference only
BluCrest Pharmaceuticals, LLC
Not stocked by us — reference only
Carbinoxamine Maleate
Neos Therapeutics, LP
Not stocked by us — reference only
Carbinoxamine Maleate
IPG Pharmaceuticals, inc.
Not stocked by us — reference only
Carbinoxamine Maleate
Aytu Therapeutics, LLC
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.